**Question:** All of the following are true about Rifampicin except:

A. Rifampicin is a bactericidal antibiotic that targets the bacterial cell wall synthesis.
B. It is an effective drug against Mycobacterium tuberculosis infection.
C. Rifampicin increases the serum levels of other medications when co-administered.
D. Rifampicin is contraindicated in patients with a history of hypersensitivity to the drug.

**Correct Answer:** .

**Core Concept:** Rifampicin is an antibiotic used in the treatment of tuberculosis. It belongs to the rifamycin family and primarily targets the bacterial cell wall synthesis. It works by inhibiting the enzyme RNA polymerase, which is essential for transcription in bacteria, leading to cell death.

**Why the Correct Answer is Right:** Rifampicin is predominantly bactericidal, meaning it directly kills the bacteria instead of inhibiting their growth. This is why option D is incorrect. Rifampicin is indeed associated with increased serum levels of other medications when co-administered, as it alters the hepatic enzyme function, but this is described in option C. In contrast, option A highlights its bactericidal action, while option B focuses on its effectiveness against Mycobacterium tuberculosis infection.

**Why Each Wrong Option is Incorrect:**

**Option A:** Rifampicin is bactericidal, not bacteriostatic like some other antibiotics. Its bactericidal action directly targets bacterial cell wall synthesis, making it effective against Mycobacterium tuberculosis.

**Option B:** While Rifampicin is effective against Mycobacterium tuberculosis infection, focusing on the infection itself does not address the incorrect aspect of the statement. Option C highlights the drug's effect on other medications, whereas option D focuses on its bactericidal action.

**Option C:** Rifampicin does affect the liver enzymes, but the question specifically states that all given options are true, making this statement true as well. The focus is on the interaction with other medications, not its bactericidal action.

**Option D:** Rifampicin is generally well-tolerated, but hypersensitivity reactions are known to occur in a small percentage of patients. The statement "contraindicated in patients with a history of hypersensitivity to the drug" is incorrect because Rifampicin is not outright contraindicated in patients with a history of hypersensitivity, but it is essential to carefully monitor these patients for adverse reactions and adjust the treatment plan accordingly.

**Core Concept:** Rifampicin is a potent antibiotic used to treat tuberculosis, targeting bacterial cell wall synthesis. It is essential to understand the correct pharmacokinetic and pharmacodynamic properties of the drug when interpreting clinical scenarios involving Rifampicin.